| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| K | -14.13% | $27.64B | +40.17% | 2.86% |
| BTCT | -8.21% | $28.19M | +79.43% | 0.00% |
| PAY | -8.15% | $3.67B | +51.19% | 0.00% |
| AIFU | -7.37% | $17.40M | +87.81% | 0.00% |
| PTGX | -7.21% | $3.27B | +47.60% | 0.00% |
| HUSA | -6.79% | $20.99M | -8.33% | 0.00% |
| XGN | -5.23% | $153.02M | +261.76% | 0.00% |
| DAVE | -4.85% | $3.07B | +532.86% | 0.00% |
| TGI | -4.72% | $2.01B | +59.69% | 0.00% |
| DSP | -4.01% | $853.41M | +32.56% | 0.00% |
| CPSH | -3.60% | $36.02M | +47.62% | 0.00% |
| VERX | -3.59% | $5.68B | -2.10% | 0.00% |
| PRA | -3.38% | $1.22B | +106.78% | 0.00% |
| BBD | -3.35% | $15.49B | +34.29% | 1.38% |
| STG | -3.33% | $38.79M | -3.01% | 0.00% |
| VSA | -3.16% | $8.59M | -17.17% | 0.00% |
| CALM | -2.68% | $5.37B | +59.42% | 6.69% |
| FATBB | -2.60% | $47.76M | -9.82% | 10.45% |
| GALT | -2.45% | $155.06M | +3.81% | 0.00% |
| DFDV | -1.99% | $363.21M | +2,422.23% | 0.00% |
Yahoo
Genmab A/S (NASDAQ:GMAB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 25, UBS analyst Xian Deng maintained a Buy rating on Genmab A/S (NASDAQ:GMAB) and set a price target of DKK2,500.00. The company reported $715 million in revenue for the first three months of 2025 compared to $603 million […]
Yahoo
Genmab A/S (NASDAQ:GMAB) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 15, Genmab A/S (NASDAQ:GMAB) announced results from its EPCORE NHL-2 trial, Arm 10. The study tested Epcoritamab, which is a bispecific antibody, in combination with R-ICE chemotherapy. The study was focused on adult patients with relapsed or refractory […]
Yahoo
Investing.com -- Morgan Stanley has begun coverage of Genmab (CSE:GMAB) (NASDAQ:GMAB) with an Equal-Weight rating and a price objective of $24, reduced slightly from the previous $25 target.
Yahoo
Media ReleaseCOPENHAGEN, Denmark; July 1, 2025 Birgitte Stephensen, Executive Vice President and Chief Legal Officer to retire after 23 years with Genmab A/SGreg Mueller joins as new Executive Vice President, General Counsel and Chief Legal Officer, effective July 1 Genmab A/S (Nasdaq: GMAB) announced today that Birgitte Stephensen, Executive Vice President and Chief Legal Officer, will retire from Genmab after a successful tenure that spanned 23 years with the company. Greg Mueller joins Genmab
Yahoo
Company Announcement COPENHAGEN, Denmark; June 30, 2025 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on June 26, 2025. On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program was expected to be completed no later than July 10, 2025. The following transactions were executed under
Yahoo
Company Announcement COPENHAGEN, Denmark; June 23, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025. The following transactions were executed under the program from June 16 to June 20, 2025: Trading PlatformNo. of sharesAverag
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IXJ | 54.83% | $3.75B | 0.41% |
| PPH | 53.24% | $584.35M | 0.36% |
| BBH | 53.08% | $339.54M | 0.35% |
| IBB | 52.31% | $5.37B | 0.45% |
| FBT | 51.19% | $1.02B | 0.54% |
| QEFA | 50.70% | $909.99M | 0.3% |
| BBEU | 50.25% | $4.59B | 0.09% |
| EWL | 50.08% | $1.33B | 0.5% |
| IEUR | 49.91% | $6.94B | 0.09% |
| IEV | 49.91% | $2.30B | 0.61% |
| FHLC | 49.41% | $2.43B | 0.084% |
| VGK | 49.35% | $26.44B | 0.06% |
| VIGI | 49.30% | $8.33B | 0.1% |
| VHT | 49.20% | $15.34B | 0.09% |
| SPEU | 48.98% | $693.33M | 0.07% |
| IDHQ | 48.88% | $463.91M | 0.29% |
| IQLT | 48.75% | $11.95B | 0.3% |
| IDLV | 48.44% | $399.11M | 0.25% |
| XLV | 48.28% | $34.17B | 0.09% |
| RSPH | 48.19% | $721.17M | 0.4% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LEU | -<0.01% | $3.36B | +328.05% | 0.00% |
| SCKT | -<0.01% | $9.82M | +10.68% | 0.00% |
| UEC | -0.06% | $2.79B | -5.29% | 0.00% |
| DDOG | 0.20% | $47.48B | +8.10% | 0.00% |
| PPC | -0.21% | $10.64B | +33.60% | 0.00% |
| PBPB | 0.22% | $381.68M | +71.88% | 0.00% |
| CIG.C | -0.24% | $2.68B | +23.72% | 0.00% |
| LITB | 0.26% | $24.26M | -71.62% | 0.00% |
| RLX | -0.32% | $2.06B | +24.86% | 0.44% |
| CNR | 0.37% | $3.81B | -28.11% | 0.98% |
| PULM | 0.41% | $23.52M | +206.67% | 0.00% |
| MNDY | -0.50% | $15.29B | +30.20% | 0.00% |
| FC | 0.51% | $263.58M | -47.68% | 0.00% |
| EE | -0.53% | $873.19M | +41.84% | 0.75% |
| HIHO | -0.55% | $7.55M | -21.86% | 4.27% |
| IMNN | 0.56% | $13.21M | -54.55% | 0.00% |
| SMWB | -0.57% | $718.96M | +32.52% | 0.00% |
| VHC | -0.61% | $69.05M | +176.10% | 0.00% |
| BTU | 0.63% | $1.80B | -34.77% | 2.04% |
| VSTA | -0.69% | $325.62M | +30.97% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -31.48% | $184.73M | 0.85% |
| TAIL | -28.60% | $94.86M | 0.59% |
| USDU | -18.86% | $129.80M | 0.5% |
| UUP | -18.37% | $196.45M | 0.77% |
| TBLL | -12.90% | $2.12B | 0.08% |
| IVOL | -12.56% | $342.69M | 1.02% |
| CLIP | -12.34% | $1.55B | 0.07% |
| TPMN | -12.04% | $31.06M | 0.65% |
| SHYM | -11.19% | $355.86M | 0.35% |
| FTSD | -11.09% | $233.11M | 0.25% |
| BTAL | -11.03% | $315.93M | 1.43% |
| CTA | -10.48% | $1.08B | 0.76% |
| CANE | -9.72% | $11.14M | 0.29% |
| XONE | -9.44% | $628.85M | 0.03% |
| STPZ | -8.20% | $443.27M | 0.2% |
| UGA | -7.28% | $76.33M | 0.97% |
| CMBS | -7.26% | $455.28M | 0.25% |
| BILZ | -6.83% | $851.85M | 0.14% |
| SHYD | -6.10% | $331.91M | 0.35% |
| TFLO | -5.93% | $6.74B | 0.15% |
Current Value
$21.701 Year Return
Current Value
$21.701 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| NYF | -0.01% | $884.52M | 0.25% |
| FMF | -0.02% | $163.23M | 0.95% |
| TIPX | 0.02% | $1.73B | 0.15% |
| IEI | -0.03% | $15.53B | 0.15% |
| BSMW | 0.07% | $107.49M | 0.18% |
| IBTJ | 0.07% | $686.15M | 0.07% |
| IBTK | 0.08% | $445.94M | 0.07% |
| SCHO | -0.08% | $10.98B | 0.03% |
| MLN | 0.21% | $513.19M | 0.24% |
| WEAT | -0.25% | $123.28M | 0.28% |
| JMST | -0.28% | $4.09B | 0.18% |
| BNDX | 0.41% | $67.46B | 0.07% |
| MMIN | -0.43% | $322.53M | 0.3% |
| CORN | 0.43% | $43.71M | 0.2% |
| IBTG | 0.43% | $1.92B | 0.07% |
| STXT | 0.47% | $128.32M | 0.49% |
| TYA | 0.48% | $147.35M | 0.15% |
| PZA | -0.58% | $2.83B | 0.28% |
| COMT | -0.62% | $617.76M | 0.48% |
| GSG | 0.63% | $1.02B | 0.75% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AZN | 48.96% | $222.71B | -7.86% | 2.18% |
| BIIB | 45.96% | $19.83B | -42.85% | 0.00% |
| GSK | 45.39% | $80.01B | +1.75% | 4.17% |
| ALC | 42.33% | $43.87B | -2.03% | 0.38% |
| SNY | 42.12% | $120.21B | -3.65% | 4.51% |
| NVS | 41.17% | $234.79B | +11.97% | 3.25% |
| ING | 40.33% | $70.12B | +28.24% | 5.20% |
| GILD | 40.23% | $142.48B | +63.70% | 2.75% |
| BRKR | 39.99% | $6.60B | -31.61% | 0.46% |
| A | 39.88% | $35.27B | -5.08% | 0.80% |
| QGEN | 39.40% | $10.51B | +14.82% | 0.52% |
| ARGX | 39.22% | $34.47B | +22.00% | 0.00% |
| ARVN | 38.74% | $575.90M | -72.43% | 0.00% |
| TECH | 38.07% | $8.53B | -28.75% | 0.60% |
| TAK | 37.68% | $46.71B | +10.75% | 4.49% |
| AMGN | 37.65% | $161.51B | -7.60% | 3.10% |
| DHR | 37.50% | $147.08B | -16.55% | 0.57% |
| CP | 37.45% | $76.68B | -1.03% | 0.70% |
| BMRN | 37.44% | $11.28B | -29.90% | 0.00% |
| PFE | 37.17% | $146.57B | -10.05% | 6.62% |
